151 related articles for article (PubMed ID: 3080606)
1. Transitional explant reduction assay--a new in vitro testing system for intravesical chemotherapy.
Weaver DJ; Barrett BA; Ross G; Adelstein EH
J Urol; 1986 Feb; 135(2):386-91. PubMed ID: 3080606
[TBL] [Abstract][Full Text] [Related]
2. [In vitro clonal assay as a predictive test of sensitivity to cytostatics in carcinoma of the human bladder].
Anton-Aparicio LM; Urmeneta J; Borras M; Balaguer R; Berián JM
Actas Urol Esp; 1985; 9(6):517-22. PubMed ID: 3938597
[No Abstract] [Full Text] [Related]
3. First-line chemotherapy of superficial bladder cancer: mitomycin vs thiotepa.
Heney NM
Urology; 1985 Oct; 26(4 Suppl):27-9. PubMed ID: 3931325
[TBL] [Abstract][Full Text] [Related]
4. Intravesical chemotherapy: studies on the relationship between osmolality and cytotoxicity.
Groos E; Masters JR
J Urol; 1986 Aug; 136(2):399-402. PubMed ID: 3090275
[TBL] [Abstract][Full Text] [Related]
5. Intravesical chemotherapy: how effective is it?
Heney NM
Urology; 1988 Mar; 31(3 Suppl):17-9. PubMed ID: 3126591
[TBL] [Abstract][Full Text] [Related]
6. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
Mobley WC; Loening SA; Narayana AS; Culp DA
Urology; 1986 Apr; 27(4):335-9. PubMed ID: 3083555
[TBL] [Abstract][Full Text] [Related]
7. In vitro drug sensitivity studies in human transitional cell carcinoma of the bladder.
Konowalchuk TW; Elhilali M; Mackillop WJ
Cancer Lett; 1987 May; 35(2):181-90. PubMed ID: 3107798
[TBL] [Abstract][Full Text] [Related]
8. In vitro study of the interaction of doxorubicin, thiotepa, and mitomycin-C, agents used for intravesical chemotherapy of superficial bladder cancer.
Seraphim LA; Perrapato SD; Slocum HK; Rustum YM; Huben RP
J Urol; 1991 Mar; 145(3):613-7. PubMed ID: 1900087
[TBL] [Abstract][Full Text] [Related]
9. Introduction and overview of intravesical therapy for superficial bladder cancer.
Soloway MS
Urology; 1988 Mar; 31(3 Suppl):5-16. PubMed ID: 3126593
[TBL] [Abstract][Full Text] [Related]
10. In vitro chemosensitivity of human bladder cancer.
Weisenthal LM; Lalude AO; Miller JB
Cancer; 1983 Apr; 51(8):1490-6. PubMed ID: 6186358
[TBL] [Abstract][Full Text] [Related]
11. A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers.
Flanigan RC; Ellison MF; Butler KM; Gomella LG; McRoberts JW
J Urol; 1986 Jul; 136(1):35-7. PubMed ID: 3086575
[TBL] [Abstract][Full Text] [Related]
12. Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity.
Groos E; Walker L; Masters JR
Cancer; 1986 Sep; 58(6):1199-203. PubMed ID: 3091241
[TBL] [Abstract][Full Text] [Related]
13. Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the bladder: a phase III prospective randomized study.
Heney NM; Koontz WW; Barton B; Soloway M; Trump DL; Hazra T; Weinstein RS
J Urol; 1988 Dec; 140(6):1390-3. PubMed ID: 3143016
[TBL] [Abstract][Full Text] [Related]
14. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
Soloway MS; Jordan AM; Murphy WM
Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268
[TBL] [Abstract][Full Text] [Related]
15. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
Zincke H; Benson RC; Hilton JF; Taylor WF
J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685
[TBL] [Abstract][Full Text] [Related]
16. Intravesical chemotherapy.
Prout GR
Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
[No Abstract] [Full Text] [Related]
17. Treatment of superficial bladder cancer with intravesical mitomycin C: analysis of immediate and long-term response in 70 patients.
Soloway MS
J Urol; 1985 Dec; 134(6):1107-9. PubMed ID: 3932684
[TBL] [Abstract][Full Text] [Related]
18. Intravesical chemotherapy: combination with Tween 80 increases cytotoxicity in vitro.
Parris CN; Masters JR; Walker MC; Newman B; Riddle P; English P
Urol Res; 1987; 15(1):17-20. PubMed ID: 3103302
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for bladder cancer.
Whitmore WF
J Urol; 1985 Dec; 134(6):1181-2. PubMed ID: 3932688
[No Abstract] [Full Text] [Related]
20. In vitro culture and chemotherapy sensitivity testing of human transitional cell carcinoma.
Lieber MM
Urol Clin North Am; 1984 Nov; 11(4):725-33. PubMed ID: 6390916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
